David D. Vail
Affiliations: | University of Nebraska at Kearney, Kearney, NE, United States | ||
| 2012 | History | Kansas State University, Manhattan, KS, United States |
Area:
Environmental and Agricultural History, History of Science, Technology, and Medicine, and Public HistoryWebsite:
https://www.unk.edu/academics/history/david-vail.phpGoogle:
"David Vail"Bio:
Parents
Sign in to add mentor| James E. Sherow | grad student | 2012 | Kansas State University (Anthropology Tree) | |
| (Guardians of abundance: Aerial application, agricultural chemicals, and toxicity in the postwar prairie west.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sánchez D, Cesarman-Maus G, Romero L, et al. (2024) The NDV-MLS as an Immunotherapeutic Strategy for Breast Cancer: Proof of Concept in Female Companion Dogs with Spontaneous Mammary Cancer. Viruses. 16 |
| Moirano S, Turek M, Sanchez D, et al. (2023) Intensity-modulated radiotherapy and chemotherapy for canine right atrial tumors: A retrospective study of seven dogs. Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association |
| Patel RB, Hernandez R, Carlson P, et al. (2021) Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade. Science Translational Medicine. 13 |
| Stevens A, Turek M, Vail D, et al. (2020) Definitive-intent intensity modulated radiotherapy for modified-Adams' stage 4 canine sinonasal cancer: A retrospective study of 29 cases (2011-2017). Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association |
| Saba C, Paoloni M, Mazcko C, et al. (2016) A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer Model. Plos One. 11: e0149194 |
| Khanna C, Vail D, Rosenberg M. (2015) Letter to Editor. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine |
| Paoloni M, Mazcko C, Selting K, et al. (2015) Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma. Plos One. 10: e0129954 |
| Paoloni M, Webb C, Mazcko C, et al. (2014) Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials. Plos One. 9: e90028 |
| Vail DD. (2012) Toxic fables: the advertising and marketing of agricultural chemicals in the great plains, 1945-1985. Endeavour. 36: 165-73 |
| Khanna C, London C, Vail D, et al. (2009) Guiding the optimal translation of new cancer treatments from canine to human cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5671-7 |